GeNeuro S.A.
GNRO.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.12 | -0.05 | 0.38 | 0.20 |
| FCF Yield | -37.56% | -36.63% | -9.04% | -13.33% |
| EV / EBITDA | -2.70 | -2.88 | -9.52 | -5.56 |
| Quality | ||||
| ROIC | -1,609.85% | -135.26% | -67.62% | -90.13% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.69 | 1.07 | 1.00 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | 22.53% | -92.29% | 8.42% | 26.84% |
| Safety | ||||
| Net Debt / EBITDA | -0.81 | -0.12 | 0.57 | 0.58 |
| Interest Coverage | -15.07 | -48.48 | -185.69 | -100.26 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -3,055.66 | -967.60 | -706.90 | -589.50 |